TY - JOUR
T1 - High-pressure headaches
T2 - Idiopathic intracranial hypertension and its mimics
AU - Peng, Kuan Po
AU - Fuh, Jong Ling
AU - Wang, Shuu Jiun
N1 - Funding Information:
The authors’ research work is supported by grants awarded to S.‑J. Wang from the Taiwan National Science Council (100‑2314‑B‑010‑019‑MY2, 100‑2314‑B‑010‑018‑MY3) and Taipei Veterans General Hospital (VGHUST101‑G7‑1‑1, V101C‑106, V101E7‑003). The authors also acknowledge National Science Council support for the Center for Dynamic Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100‑2911‑I‑ 008‑001), Brain Research Center, National Yang‑Ming University and a grant from the Ministry of Education, Aim for the Top University Plan.
PY - 2012/12
Y1 - 2012/12
N2 - Idiopathic intracranial hypertension (IIH) is a rare disorder that typically affects obese women of childbearing age, but can also occur in paediatric populations. Patients usually present with diffuse, daily headache and visual disturbances, but either symptom can occur in isolation. Patients with IIH often have papilloedema; however, IIH without papilloedema is fairly common in patients with chronic daily headache. The pathogenesis of IIH is unknown; the high incidence of comorbid bilateral transverse sinus stenosis (BTSS) in patients with IIH suggests that the two conditions are linked, although no direct causal relationship has been established. Cerebrospinal fluid (CSF) pressure monitoring or lumbar puncture - which provides immediate symptomatic relief - are important in making a diagnosis of IIH. Current treatments for IIH include weight reduction, medical treatment, CSF diversion surgery, optic nerve sheath fenestration and, potentially, endovascular stenting (in patients with BTSS). Prevention of visual loss (which can be substantial) is the main goal of treatment. Residual headache and IIH recurrence are not uncommon after treatment, and regular follow-up is, therefore, warranted even in patients who achieve remission. This Review provides an update of current knowledge of the aetiology, pathophysiology and treatment of IIH.
AB - Idiopathic intracranial hypertension (IIH) is a rare disorder that typically affects obese women of childbearing age, but can also occur in paediatric populations. Patients usually present with diffuse, daily headache and visual disturbances, but either symptom can occur in isolation. Patients with IIH often have papilloedema; however, IIH without papilloedema is fairly common in patients with chronic daily headache. The pathogenesis of IIH is unknown; the high incidence of comorbid bilateral transverse sinus stenosis (BTSS) in patients with IIH suggests that the two conditions are linked, although no direct causal relationship has been established. Cerebrospinal fluid (CSF) pressure monitoring or lumbar puncture - which provides immediate symptomatic relief - are important in making a diagnosis of IIH. Current treatments for IIH include weight reduction, medical treatment, CSF diversion surgery, optic nerve sheath fenestration and, potentially, endovascular stenting (in patients with BTSS). Prevention of visual loss (which can be substantial) is the main goal of treatment. Residual headache and IIH recurrence are not uncommon after treatment, and regular follow-up is, therefore, warranted even in patients who achieve remission. This Review provides an update of current knowledge of the aetiology, pathophysiology and treatment of IIH.
UR - http://www.scopus.com/inward/record.url?scp=84870826355&partnerID=8YFLogxK
U2 - 10.1038/nrneurol.2012.223
DO - 10.1038/nrneurol.2012.223
M3 - Review article
C2 - 23165338
AN - SCOPUS:84870826355
SN - 1759-4758
VL - 8
SP - 700
EP - 710
JO - Nature Reviews Neurology
JF - Nature Reviews Neurology
IS - 12
ER -